Immatics NV Schedule 13G passive stakes

Vestal Point Capital, LP has reduced its ownership in Immatics N.V. to 4.6%, crossing below the 5% regulatory reporting threshold.

The Toronto-Dominion Bank has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Immatics N.V. ordinary shares as of March 31, 2026.

RTW Investments, LP and Roderick Wong have reported a significant beneficial ownership stake of 9.6% in Immatics N.V., holding over 12.8 million ordinary shares.

RTW Investments, LP and Roderick Wong have reported an 8.5% beneficial ownership stake in Immatics N.V., holding 11,433,354 ordinary shares.

Suvretta Capital Management, LLC and its affiliates have disclosed an 8.3% beneficial ownership stake in Immatics N.V. ordinary shares.

Baker Bros. Advisors and its affiliates have disclosed an unchanged 9.95% beneficial ownership stake in Immatics N.V., totaling 12,094,094 ordinary shares.

RTW Investments, LP and Roderick Wong, M.D. have filed an amendment to their Schedule 13G, reporting a continued 7.3% beneficial ownership in Immatics N.V. as of September 30, 2025.

Baker Bros. Advisors and its affiliates have increased their beneficial ownership in Immatics N.V. to 8.4% of outstanding ordinary shares.

T. Rowe Price Investment Management, Inc. has reported a 15.1% beneficial ownership stake in Immatics NV, holding 18,328,455 common shares.

Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen report significant beneficial ownership in Immatics N.V., with Suvretta and Cowen holding 9.9% each.

Wellington Management Group and its affiliates report a reduced beneficial ownership in Immatics N.V. common stock, now holding 4.38%.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, revealing a beneficial ownership of 7.06% in Immatics N.V.'s common stock as of March 31, 2025.

Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen have filed an amended Schedule 13G, disclosing their beneficial ownership of 7.5% and 6.7% respectively, in Immatics N.V.'s ordinary shares as of March 31, 2025.

T. Rowe Price Investment Management, Inc. has reported a beneficial ownership of 11.6% of Immatics NV's common stock as of February 28, 2025.

Baker Bros. Advisors and its principals have filed an Amendment No. 3 to Schedule 13G, reporting a continued beneficial ownership of 6.0% of Immatics N.V.'s Ordinary Shares as of December 31, 2024.

Vestal Point Capital, LP and its Chief Investment Officer, Ryan Wilder, have disclosed a beneficial ownership of 5.3% in Immatics N.V., holding 6,275,000 ordinary shares.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, revealing a significant 8.7% beneficial ownership stake in Immatics NV as of December 31, 2024.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a 5.5% beneficial ownership stake in Immatics N.V. as of December 31, 2024.

Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen have jointly filed a Schedule 13G, revealing beneficial ownership of 6.5% of Immatics N.V.'s ordinary shares.